REPORT ID 10243

Global Double Barreled Antibodies Drug Sales Market Report 2017

Publish Date
16-Nov-17
Pages
112
Format
Electronic (PDF)

In this report, the global Double Barreled Antibodies Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Double Barreled Antibodies Drug for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Double Barreled Antibodies Drug market competition by top manufacturers/players, with Double Barreled Antibodies Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amgen Inc.
    F. Hoffman La Roche Ltd.
    AbbVie Inc.
    OncoMed Pharmaceuticals, Inc.
    Glenmark Pharmaceuticals Limited
    Xencor, Inc.
    MacroGenics, Inc.
    Aptevo Therapeutics Inc.
    Ligand Pharmaceuticals, Inc.
    Regeneron Pharmaceuticals, Inc.
    Fresenius SE & Co. KGaA
    Merus N.V.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Removab
    BLINCYTO
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Lung Cancer
    Brain Cancer
    Liver Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Double Barreled Antibodies Drug Sales Market Report 2017
1 Double Barreled Antibodies Drug Market Overview
    1.1 Product Overview and Scope of Double Barreled Antibodies Drug
    1.2 Classification of Double Barreled Antibodies Drug by Product Category
        1.2.1 Global Double Barreled Antibodies Drug Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Double Barreled Antibodies Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Removab
        1.2.4 BLINCYTO
        1.2.5 Others
    1.3 Global Double Barreled Antibodies Drug Market by Application/End Users
        1.3.1 Global Double Barreled Antibodies Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Lung Cancer
        1.3.3 Brain Cancer
        1.3.4 Liver Cancer
        1.3.5 Others
    1.4 Global Double Barreled Antibodies Drug Market by Region
        1.4.1 Global Double Barreled Antibodies Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Double Barreled Antibodies Drug Status and Prospect (2012-2022)
        1.4.3 China Double Barreled Antibodies Drug Status and Prospect (2012-2022)
        1.4.4 Europe Double Barreled Antibodies Drug Status and Prospect (2012-2022)
        1.4.5 Japan Double Barreled Antibodies Drug Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Double Barreled Antibodies Drug Status and Prospect (2012-2022)
        1.4.7 India Double Barreled Antibodies Drug Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Double Barreled Antibodies Drug (2012-2022)
        1.5.1 Global Double Barreled Antibodies Drug Sales and Growth Rate (2012-2022)
        1.5.2 Global Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2022)

2 Global Double Barreled Antibodies Drug Competition by Players/Suppliers, Type and Application
     2.1 Global Double Barreled Antibodies Drug Market Competition by Players/Suppliers
        2.1.1 Global Double Barreled Antibodies Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Double Barreled Antibodies Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Double Barreled Antibodies Drug (Volume and Value) by Type
        2.2.1 Global Double Barreled Antibodies Drug Sales and Market Share by Type (2012-2017)
        2.2.2 Global Double Barreled Antibodies Drug Revenue and Market Share by Type (2012-2017)
    2.3 Global Double Barreled Antibodies Drug (Volume and Value) by Region
        2.3.1 Global Double Barreled Antibodies Drug Sales and Market Share by Region (2012-2017)
        2.3.2 Global Double Barreled Antibodies Drug Revenue and Market Share by Region (2012-2017)
    2.4 Global Double Barreled Antibodies Drug (Volume) by Application

3 United States Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    3.1 United States Double Barreled Antibodies Drug Sales and Value (2012-2017)
        3.1.1 United States Double Barreled Antibodies Drug Sales and Growth Rate (2012-2017)
        3.1.2 United States Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        3.1.3 United States Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    3.2 United States Double Barreled Antibodies Drug Sales Volume and Market Share by Players
    3.3 United States Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    3.4 United States Double Barreled Antibodies Drug Sales Volume and Market Share by Application

4 China Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    4.1 China Double Barreled Antibodies Drug Sales and Value (2012-2017)
        4.1.1 China Double Barreled Antibodies Drug Sales and Growth Rate (2012-2017)
        4.1.2 China Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        4.1.3 China Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    4.2 China Double Barreled Antibodies Drug Sales Volume and Market Share by Players
    4.3 China Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    4.4 China Double Barreled Antibodies Drug Sales Volume and Market Share by Application

5 Europe Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    5.1 Europe Double Barreled Antibodies Drug Sales and Value (2012-2017)
        5.1.1 Europe Double Barreled Antibodies Drug Sales and Growth Rate (2012-2017)
        5.1.2 Europe Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    5.2 Europe Double Barreled Antibodies Drug Sales Volume and Market Share by Players
    5.3 Europe Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    5.4 Europe Double Barreled Antibodies Drug Sales Volume and Market Share by Application

6 Japan Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    6.1 Japan Double Barreled Antibodies Drug Sales and Value (2012-2017)
        6.1.1 Japan Double Barreled Antibodies Drug Sales and Growth Rate (2012-2017)
        6.1.2 Japan Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    6.2 Japan Double Barreled Antibodies Drug Sales Volume and Market Share by Players
    6.3 Japan Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    6.4 Japan Double Barreled Antibodies Drug Sales Volume and Market Share by Application

7 Southeast Asia Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    7.1 Southeast Asia Double Barreled Antibodies Drug Sales and Value (2012-2017)
        7.1.1 Southeast Asia Double Barreled Antibodies Drug Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    7.2 Southeast Asia Double Barreled Antibodies Drug Sales Volume and Market Share by Players
    7.3 Southeast Asia Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    7.4 Southeast Asia Double Barreled Antibodies Drug Sales Volume and Market Share by Application

8 India Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    8.1 India Double Barreled Antibodies Drug Sales and Value (2012-2017)
        8.1.1 India Double Barreled Antibodies Drug Sales and Growth Rate (2012-2017)
        8.1.2 India Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        8.1.3 India Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    8.2 India Double Barreled Antibodies Drug Sales Volume and Market Share by Players
    8.3 India Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    8.4 India Double Barreled Antibodies Drug Sales Volume and Market Share by Application

9 Global Double Barreled Antibodies Drug Players/Suppliers Profiles and Sales Data
    9.1 Amgen Inc.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Amgen Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 F. Hoffman La Roche Ltd.
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 AbbVie Inc.
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 AbbVie Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 OncoMed Pharmaceuticals, Inc.
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Glenmark Pharmaceuticals Limited
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Xencor, Inc.
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Xencor, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 MacroGenics, Inc.
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 MacroGenics, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Aptevo Therapeutics Inc.
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Ligand Pharmaceuticals, Inc.
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Regeneron Pharmaceuticals, Inc.
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Fresenius SE & Co. KGaA
    9.12 Merus N.V.

10 Double Barreled Antibodies Drug Maufacturing Cost Analysis
    10.1 Double Barreled Antibodies Drug Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Double Barreled Antibodies Drug
    10.3 Manufacturing Process Analysis of Double Barreled Antibodies Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Double Barreled Antibodies Drug Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Double Barreled Antibodies Drug Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Double Barreled Antibodies Drug Market Forecast (2017-2022)
    14.1 Global Double Barreled Antibodies Drug Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Double Barreled Antibodies Drug Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Double Barreled Antibodies Drug Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Double Barreled Antibodies Drug Price and Trend Forecast (2017-2022)
    14.2 Global Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Double Barreled Antibodies Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Double Barreled Antibodies Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Double Barreled Antibodies Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Double Barreled Antibodies Drug Sales Forecast by Type (2017-2022)
       14.3.2 Global Double Barreled Antibodies Drug Revenue Forecast by Type (2017-2022)
       14.3.3 Global Double Barreled Antibodies Drug Price Forecast by Type (2017-2022)
    14.4 Global Double Barreled Antibodies Drug Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation